175 related articles for article (PubMed ID: 36806702)
21. TET2 inhibits the proliferation and metastasis of lung adenocarcinoma cells via activation of the cGAS-STING signalling pathway.
Cheng G; Wu J; Ji M; Hu W; Wu C; Jiang J
BMC Cancer; 2023 Sep; 23(1):825. PubMed ID: 37667220
[TBL] [Abstract][Full Text] [Related]
22. Expression of TET and 5-HmC in Trophoblast Villi of Women with Normal Pregnancy and with Early Pregnancy Loss.
Wu AH; Yang DY; Liu YD; Chen X; Chen XL; Lu S; Chen SL
Curr Med Sci; 2018 Jun; 38(3):505-512. PubMed ID: 30074219
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
[TBL] [Abstract][Full Text] [Related]
24. Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX.
Ko M; An J; Bandukwala HS; Chavez L; Aijö T; Pastor WA; Segal MF; Li H; Koh KP; Lähdesmäki H; Hogan PG; Aravind L; Rao A
Nature; 2013 May; 497(7447):122-6. PubMed ID: 23563267
[TBL] [Abstract][Full Text] [Related]
25. TET enzymes are successively expressed during human spermatogenesis and their expression level is pivotal for male fertility.
Ni K; Dansranjavin T; Rogenhofer N; Oeztuerk N; Deuker J; Bergmann M; Schuppe HC; Wagenlehner F; Weidner W; Steger K; Schagdarsurengin U
Hum Reprod; 2016 Jul; 31(7):1411-24. PubMed ID: 27141042
[TBL] [Abstract][Full Text] [Related]
26. Loss of TET2 with reduced genomic 5-hmC is associated with adverse-risk AML.
Pethusamy K; Seethy A; Dhar R; Karmakar A; Chaudhary S; Bakhshi S; Palanichamy JK; Chopra A; Chauhan SS; Karmakar S
Leuk Lymphoma; 2022 Dec; 63(14):3426-3432. PubMed ID: 36165590
[TBL] [Abstract][Full Text] [Related]
27. Ten-Eleven Translocation Genes are Downregulated in Endometriosis.
Roca FJ; Loomans HA; Wittman AT; Creighton CJ; Hawkins SM
Curr Mol Med; 2016; 16(3):288-98. PubMed ID: 26917261
[TBL] [Abstract][Full Text] [Related]
28. TET proteins and 5-methylcytosine oxidation in hematological cancers.
Ko M; An J; Pastor WA; Koralov SB; Rajewsky K; Rao A
Immunol Rev; 2015 Jan; 263(1):6-21. PubMed ID: 25510268
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation of TET2 by AMPK is indispensable in myogenic differentiation.
Zhang T; Guan X; Choi UL; Dong Q; Lam MMT; Zeng J; Xiong J; Wang X; Poon TCW; Zhang H; Zhang X; Wang H; Xie R; Zhu B; Li G
Epigenetics Chromatin; 2019 Jun; 12(1):32. PubMed ID: 31164154
[TBL] [Abstract][Full Text] [Related]
30. TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression.
Takayama K; Misawa A; Suzuki T; Takagi K; Hayashizaki Y; Fujimura T; Homma Y; Takahashi S; Urano T; Inoue S
Nat Commun; 2015 Sep; 6():8219. PubMed ID: 26404510
[TBL] [Abstract][Full Text] [Related]
31. Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer.
Du C; Kurabe N; Matsushima Y; Suzuki M; Kahyo T; Ohnishi I; Tanioka F; Tajima S; Goto M; Yamada H; Tao H; Shinmura K; Konno H; Sugimura H
Gastric Cancer; 2015 Jul; 18(3):516-25. PubMed ID: 25098926
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET Proteins.
Pirola CJ; Scian R; Gianotti TF; Dopazo H; Rohr C; Martino JS; Castaño GO; Sookoian S
Medicine (Baltimore); 2015 Sep; 94(36):e1480. PubMed ID: 26356709
[TBL] [Abstract][Full Text] [Related]
33. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.
Lian CG; Xu Y; Ceol C; Wu F; Larson A; Dresser K; Xu W; Tan L; Hu Y; Zhan Q; Lee CW; Hu D; Lian BQ; Kleffel S; Yang Y; Neiswender J; Khorasani AJ; Fang R; Lezcano C; Duncan LM; Scolyer RA; Thompson JF; Kakavand H; Houvras Y; Zon LI; Mihm MC; Kaiser UB; Schatton T; Woda BA; Murphy GF; Shi YG
Cell; 2012 Sep; 150(6):1135-46. PubMed ID: 22980977
[TBL] [Abstract][Full Text] [Related]
34. Adult T cell leukemia aggressivenness correlates with loss of both 5-hydroxymethylcytosine and TET2 expression.
Marçais A; Waast L; Bruneau J; Hanssens K; Asnafi V; Gaulard P; Suarez F; Dubreuil P; Gessain A; Hermine O; Pique C
Oncotarget; 2017 Aug; 8(32):52256-52268. PubMed ID: 28881727
[TBL] [Abstract][Full Text] [Related]
35. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
Poole CJ; Lodh A; Choi JH; van Riggelen J
Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
[TBL] [Abstract][Full Text] [Related]
36. Prognostic values of 5-hmC, 5-mC and TET2 in epithelial ovarian cancer.
Zhang LY; Li PL; Wang TZ; Zhang XC
Arch Gynecol Obstet; 2015 Oct; 292(4):891-7. PubMed ID: 25827305
[TBL] [Abstract][Full Text] [Related]
37. Dynamic expression of TET1, TET2, and TET3 dioxygenases in mouse and human placentas throughout gestation.
Rakoczy J; Padmanabhan N; Krzak AM; Kieckbusch J; Cindrova-Davies T; Watson ED
Placenta; 2017 Nov; 59():46-56. PubMed ID: 29108636
[TBL] [Abstract][Full Text] [Related]
38. Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1.
Liu C; Liu L; Chen X; Shen J; Shan J; Xu Y; Yang Z; Wu L; Xia F; Bie P; Cui Y; Bian XW; Qian C
PLoS One; 2013; 8(5):e62828. PubMed ID: 23671639
[TBL] [Abstract][Full Text] [Related]
39. Regulation of TET2 gene expression and 5mC oxidation in breast cancer cells by estrogen signaling.
Zhu X; Xiong L; Lyu R; Shen Y; Liu L; Li S; Argueta C; Tan L
Biochem Biophys Res Commun; 2022 Jan; 589():240-246. PubMed ID: 34929447
[TBL] [Abstract][Full Text] [Related]
40. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS.
Deplus R; Delatte B; Schwinn MK; Defrance M; Méndez J; Murphy N; Dawson MA; Volkmar M; Putmans P; Calonne E; Shih AH; Levine RL; Bernard O; Mercher T; Solary E; Urh M; Daniels DL; Fuks F
EMBO J; 2013 Mar; 32(5):645-55. PubMed ID: 23353889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
